NCT05017870View on ClinicalTrials.gov

[KSR-001-P01]Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristic of KSR-001

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 2, 2018

Primary Completion Date

June 14, 2019

Study Completion Date

January 15, 2020

Conditions
Dry Eye Syndromes
Interventions
DRUG

KSR-001

(0 day) eye drops received one drop to both eyes once a day (1\~5 day) eyedrops recieved one drop to both eyes four times a day

DRUG

KSR-004

(0 day) eye drops received one drop to both eyes once a day (1\~5 day) eyedrops recieved one drop to both eyes four times a day

DRUG

KSR-001-02

KSR-001-02

DRUG

KSR-001-03

KSR-001-03

Trial Locations (1)

Unknown

Kukje Pharma, Seongnam-si

Sponsors

Lead Sponsor

Kukje Pharma
All Listed Sponsors
lead

Kukje Pharma

OTHER